{"hands_on_practices": [{"introduction": "The first crucial consequence of a coding variant is its effect on protein stability, as a protein must fold correctly to perform its function. This practice exercise delves into the thermodynamic principles of protein folding, allowing you to calculate the fraction of functional protein remaining when a variant increases the Gibbs free energy of folding ($\\Delta G$) [@problem_id:5032663]. By mastering this calculation, you will gain a quantitative understanding of how even subtle changes in stability can lead to a significant loss of function.", "problem": "A clinically observed missense variant in a protein-coding gene reduces protein stability by increasing the Gibbs free energy change of folding. Assume a two-state folding model in which the native state ($N$) and the unfolded state ($U$) are in equilibrium, and let the equilibrium constant be $K = \\frac{[N]}{[U]}$. Use the thermodynamic relation $\\Delta G = - R T \\ln K$, which holds for any reaction at equilibrium, and the definition of the native-state fraction $f_{N} = \\frac{[N]}{[N] + [U]}$, to derive an expression for $f_{N}$ in terms of $\\Delta G$, $R$, and $T$. Then compute the native-state fraction at body temperature for the variant, given that the wild-type folding free energy at $37\\,^{\\circ}\\mathrm{C}$ is $\\Delta G_{\\mathrm{WT}} = -5.0\\,\\mathrm{kcal\\,mol^{-1}}$ and the variant increases the folding free energy by $\\Delta\\Delta G = +2.0\\,\\mathrm{kcal\\,mol^{-1}}$ (so that $\\Delta G_{\\mathrm{variant}} = \\Delta G_{\\mathrm{WT}} + \\Delta\\Delta G$). Use the gas constant $R = 1.987\\,\\mathrm{cal\\,mol^{-1}\\,K^{-1}}$ and absolute temperature $T = 310\\,\\mathrm{K}$. Ensure energy units are consistent within your calculations. Round your final numerical answer for $f_{N}$ to four significant figures and express it as a decimal fraction with no unit.", "solution": "The problem statement will first be validated against the specified criteria.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n- **Model**: A two-state folding equilibrium between a native state ($N$) and an unfolded state ($U$).\n- **Equilibrium Constant**: $K = \\frac{[N]}{[U]}$.\n- **Thermodynamic Relation**: $\\Delta G = - R T \\ln K$.\n- **Native-State Fraction**: $f_{N} = \\frac{[N]}{[N] + [U]}$.\n- **Wild-Type Folding Free Energy**: $\\Delta G_{\\mathrm{WT}} = -5.0\\,\\mathrm{kcal\\,mol^{-1}}$.\n- **Temperature**: $T = 37\\,^{\\circ}\\mathrm{C}$, which is given as $T = 310\\,\\mathrm{K}$.\n- **Effect of Variant**: The variant increases the folding free energy by $\\Delta\\Delta G = +2.0\\,\\mathrm{kcal\\,mol^{-1}}$.\n- **Variant Folding Free Energy**: $\\Delta G_{\\mathrm{variant}} = \\Delta G_{\\mathrm{WT}} + \\Delta\\Delta G$.\n- **Gas Constant**: $R = 1.987\\,\\mathrm{cal\\,mol^{-1}\\,K^{-1}}$.\n- **Task 1**: Derive an expression for $f_{N}$ in terms of $\\Delta G$, $R$, and $T$.\n- **Task 2**: Compute the numerical value of $f_{N}$ for the variant at $T = 310\\,\\mathrm{K}$.\n- **Instruction**: Ensure energy units are consistent.\n- **Instruction**: Round the final numerical answer to four significant figures.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Groundedness**: The problem is scientifically sound. It uses the fundamental principles of chemical thermodynamics ($\\Delta G = - R T \\ln K$) applied to a standard biophysical model (two-state protein folding). The values for folding free energy and the effect of a mutation are realistic.\n- **Well-Posedness**: The problem is well-posed. It requests a specific derivation and a subsequent calculation, providing all necessary definitions and data to arrive at a unique solution.\n- **Objectivity**: The problem is stated in objective, quantitative terms, free from ambiguity or subjective claims.\n- **Completeness and Consistency**: The problem is self-contained. While there is a difference in energy units between $\\Delta G$ ($\\mathrm{kcal\\,mol^{-1}}$) and $R$ ($\\mathrm{cal\\,mol^{-1}\\,K^{-1}}$), the problem explicitly directs the user to \"Ensure energy units are consistent,\" which is a standard requirement in physical calculations, not a flaw in the problem statement. All necessary information is provided.\n\n**Step 3: Verdict and Action**\nThe problem is deemed valid as it is scientifically grounded, well-posed, objective, and self-contained. A full solution will be provided.\n\n### Solution\n\nThe first step is to derive an expression for the native-state fraction, $f_{N}$, as a function of the Gibbs free energy change of folding, $\\Delta G$, the gas constant, $R$, and the absolute temperature, $T$. We begin with the definition of $f_{N}$:\n$$f_{N} = \\frac{[N]}{[N] + [U]}$$\nTo introduce the equilibrium constant $K = \\frac{[N]}{[U]}$, we can divide both the numerator and the denominator of the expression for $f_{N}$ by the concentration of the unfolded state, $[U]$:\n$$f_{N} = \\frac{\\frac{[N]}{[U]}}{\\frac{[N]}{[U]} + \\frac{[U]}{[U]}} = \\frac{K}{K + 1}$$\nNext, we use the given thermodynamic relation to express $K$ in terms of $\\Delta G$, $R$, and $T$.\n$$\\Delta G = - R T \\ln K$$\nSolving for $\\ln K$ gives:\n$$\\ln K = -\\frac{\\Delta G}{R T}$$\nExponentiating both sides yields the expression for $K$:\n$$K = \\exp\\left(-\\frac{\\Delta G}{R T}\\right)$$\nSubstituting this expression for $K$ into our equation for $f_{N}$:\n$$f_{N} = \\frac{\\exp\\left(-\\frac{\\Delta G}{R T}\\right)}{\\exp\\left(-\\frac{\\Delta G}{R T}\\right) + 1}$$\nTo simplify this expression into a more conventional form, we can multiply the numerator and the denominator by $\\exp\\left(\\frac{\\Delta G}{R T}\\right)$:\n$$f_{N} = \\frac{\\exp\\left(-\\frac{\\Delta G}{R T}\\right) \\cdot \\exp\\left(\\frac{\\Delta G}{R T}\\right)}{\\left(\\exp\\left(-\\frac{\\Delta G}{R T}\\right) + 1\\right) \\cdot \\exp\\left(\\frac{\\Delta G}{R T}\\right)} = \\frac{\\exp(0)}{\\exp(0) + \\exp\\left(\\frac{\\Delta G}{R T}\\right)}$$\nSince $\\exp(0)=1$, the final expression for the native-state fraction is:\n$$f_{N} = \\frac{1}{1 + \\exp\\left(\\frac{\\Delta G}{R T}\\right)}$$\nThis completes the derivation part of the problem.\n\nThe second step is to compute the numerical value of $f_{N}$ for the specified variant. First, we calculate the folding free energy of the variant, $\\Delta G_{\\mathrm{variant}}$.\n$$\\Delta G_{\\mathrm{variant}} = \\Delta G_{\\mathrm{WT}} + \\Delta\\Delta G$$\nSubstituting the given values:\n$$\\Delta G_{\\mathrm{variant}} = -5.0\\,\\mathrm{kcal\\,mol^{-1}} + 2.0\\,\\mathrm{kcal\\,mol^{-1}} = -3.0\\,\\mathrm{kcal\\,mol^{-1}}$$\nNext, we must ensure the units are consistent before applying the derived formula. The gas constant $R$ is given in $\\mathrm{cal\\,mol^{-1}\\,K^{-1}}$, while $\\Delta G_{\\mathrm{variant}}$ is in $\\mathrm{kcal\\,mol^{-1}}$. We convert $\\Delta G_{\\mathrm{variant}}$ to $\\mathrm{cal\\,mol^{-1}}$:\n$$\\Delta G_{\\mathrm{variant}} = -3.0\\,\\mathrm{kcal\\,mol^{-1}} \\times \\frac{1000\\,\\mathrm{cal}}{1\\,\\mathrm{kcal}} = -3000\\,\\mathrm{cal\\,mol^{-1}}$$\nNow, we can compute the dimensionless argument of the exponential function, $\\frac{\\Delta G}{R T}$, using $\\Delta G = -3000\\,\\mathrm{cal\\,mol^{-1}}$, $R = 1.987\\,\\mathrm{cal\\,mol^{-1}\\,K^{-1}}$, and $T = 310\\,\\mathrm{K}$.\n$$\\frac{\\Delta G}{R T} = \\frac{-3000\\,\\mathrm{cal\\,mol^{-1}}}{(1.987\\,\\mathrm{cal\\,mol^{-1}\\,K^{-1}}) \\times (310\\,\\mathrm{K})}$$\nThe product in the denominator is:\n$$R T = 1.987 \\times 310\\,\\mathrm{cal\\,mol^{-1}} = 615.97\\,\\mathrm{cal\\,mol^{-1}}$$\nThus, the exponent is:\n$$\\frac{\\Delta G}{R T} = \\frac{-3000}{615.97} \\approx -4.87036706$$\nFinally, we substitute this value into the expression for $f_{N}$:\n$$f_{N} = \\frac{1}{1 + \\exp(-4.87036706)}$$\nCalculating the exponential term:\n$$\\exp(-4.87036706) \\approx 0.00767064$$\nSubstituting this back into the formula for $f_{N}$:\n$$f_{N} = \\frac{1}{1 + 0.00767064} = \\frac{1}{1.00767064} \\approx 0.9923864$$\nThe problem requires the answer to be rounded to four significant figures.\n$$f_{N} \\approx 0.9924$$", "answer": "$$\\boxed{0.9924}$$", "id": "5032663"}, {"introduction": "Beyond stability, a missense variant can directly alter an enzyme's catalytic efficiency and its affinity for its substrate. In this problem, you will apply the classic Michaelis-Menten model to quantify the functional impact of a variant by calculating reaction velocities for both the wild-type and mutant enzymes at different substrate concentrations [@problem_id:5032692]. This will solidify your understanding of key kinetic parameters like $K_M$ and $k_{\\mathrm{cat}}$ and their importance in determining a variant's physiological consequence.", "problem": "A missense coding variant in a human metabolic enzyme alters its kinetic properties relative to the wild type. According to the Central Dogma of Molecular Biology (DNA $\\rightarrow$ RNA $\\rightarrow$ protein), a change in the protein sequence can modify enzyme function by changing the turnover number and substrate affinity. The variant is observed to have a reduced turnover number and decreased apparent substrate affinity compared to the wild type, characterized by the following parameters: wild-type turnover number $k_{\\mathrm{cat}}=100\\ \\mathrm{s}^{-1}$, wild-type Michaelis constant $K_{M}=20\\ \\mu\\mathrm{M}$; variant turnover number $k_{\\mathrm{cat}}=10\\ \\mathrm{s}^{-1}$, variant Michaelis constant $K_{M}=200\\ \\mu\\mathrm{M}$. Assume an initial-rate regime where product accumulation is negligible and substrate concentration is much greater than enzyme concentration, with total enzyme concentration $[E]_{T}=50\\ \\mathrm{nM}$. Using the steady-state framework for the single-substrate enzyme reaction $E+S\\rightleftharpoons ES\\rightarrow E+P$, compute the initial velocities for both wild-type and variant enzymes at substrate concentrations $[S]=5\\ \\mu\\mathrm{M}$, $[S]=20\\ \\mu\\mathrm{M}$, and $[S]=200\\ \\mu\\mathrm{M}$. Express all velocities in $\\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$, round your results to four significant figures, and report the six values as a single row matrix in the order: wild-type at $[S]=5\\ \\mu\\mathrm{M}$, wild-type at $[S]=20\\ \\mu\\mathrm{M}$, wild-type at $[S]=200\\ \\mu\\mathrm{M}$, variant at $[S]=5\\ \\mu\\mathrm{M}$, variant at $[S]=20\\ \\mu\\mathrm{M}$, variant at $[S]=200\\ \\mu\\mathrm{M}$.", "solution": "The problem requires the calculation of initial reaction velocities for a wild-type enzyme and a missense variant using the Michaelis-Menten model. The reaction follows the scheme $E+S\\rightleftharpoons ES\\rightarrow E+P$.\n\nThe initial velocity $v_0$ of a single-substrate enzyme reaction following Michaelis-Menten kinetics is given by the equation:\n$$ v_0 = \\frac{V_{\\mathrm{max}}[S]}{K_M + [S]} $$\nwhere $V_{\\mathrm{max}}$ is the maximum velocity, $K_M$ is the Michaelis constant, and $[S]$ is the substrate concentration. The maximum velocity $V_{\\mathrm{max}}$ is related to the turnover number $k_{\\mathrm{cat}}$ and the total enzyme concentration $[E]_T$ by the expression:\n$$ V_{\\mathrm{max}} = k_{\\mathrm{cat}} [E]_T $$\nSubstituting this into the Michaelis-Menten equation yields the form we will use for calculation:\n$$ v_0 = \\frac{k_{\\mathrm{cat}} [E]_T [S]}{K_M + [S]} $$\nThe problem provides data with mixed units. The substrate concentration $[S]$ and Michaelis constant $K_M$ are in $\\mu\\mathrm{M}$, while the total enzyme concentration $[E]_T$ is in $\\mathrm{nM}$. To ensure dimensional consistency and to obtain the final velocity in the requested units of $\\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$, we must express all concentration terms in $\\mu\\mathrm{M}$. The turnover number $k_{\\mathrm{cat}}$ is given in $\\mathrm{s}^{-1}$.\nThe total enzyme concentration is given as $[E]_T = 50\\ \\mathrm{nM}$. We convert this to $\\mu\\mathrm{M}$:\n$$ [E]_T = 50\\ \\mathrm{nM} = 50 \\times 10^{-3}\\ \\mu\\mathrm{M} = 0.050\\ \\mu\\mathrm{M} $$\n\nWe will now calculate the initial velocities for both the wild-type and variant enzymes at the three specified substrate concentrations.\n\n**1. Wild-Type (WT) Enzyme Calculations**\nThe parameters for the wild-type enzyme are $k_{\\mathrm{cat, WT}} = 100\\ \\mathrm{s}^{-1}$ and $K_{M, \\mathrm{WT}} = 20\\ \\mu\\mathrm{M}$.\nFirst, we determine the maximum velocity for the wild-type enzyme:\n$$ V_{\\mathrm{max, WT}} = k_{\\mathrm{cat, WT}} [E]_T = (100\\ \\mathrm{s}^{-1})(0.050\\ \\mu\\mathrm{M}) = 5.0\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nNow we compute the velocities at the specified substrate concentrations:\n\na) For $[S] = 5\\ \\mu\\mathrm{M}$:\n$$ v_{0, \\mathrm{WT}} = \\frac{(5.0\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(5\\ \\mu\\mathrm{M})}{20\\ \\mu\\mathrm{M} + 5\\ \\mu\\mathrm{M}} = \\frac{25}{25}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = 1.0\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nRounded to four significant figures, the velocity is $1.000\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\nb) For $[S] = 20\\ \\mu\\mathrm{M}$ (which is equal to $K_{M, \\mathrm{WT}}$):\n$$ v_{0, \\mathrm{WT}} = \\frac{(5.0\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(20\\ \\mu\\mathrm{M})}{20\\ \\mu\\mathrm{M} + 20\\ \\mu\\mathrm{M}} = \\frac{100}{40}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = 2.5\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nAs expected, the velocity is exactly half of $V_{\\mathrm{max, WT}}$. Rounded to four significant figures, the velocity is $2.500\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\nc) For $[S] = 200\\ \\mu\\mathrm{M}$:\n$$ v_{0, \\mathrm{WT}} = \\frac{(5.0\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(200\\ \\mu\\mathrm{M})}{20\\ \\mu\\mathrm{M} + 200\\ \\mu\\mathrm{M}} = \\frac{1000}{220}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = \\frac{50}{11}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} \\approx 4.54545\\dots\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nRounded to four significant figures, the velocity is $4.545\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\n**2. Variant (VAR) Enzyme Calculations**\nThe parameters for the variant enzyme are $k_{\\mathrm{cat, VAR}} = 10\\ \\mathrm{s}^{-1}$ and $K_{M, \\mathrm{VAR}} = 200\\ \\mu\\mathrm{M}$.\nFirst, we determine the maximum velocity for the variant enzyme:\n$$ V_{\\mathrm{max, VAR}} = k_{\\mathrm{cat, VAR}} [E]_T = (10\\ \\mathrm{s}^{-1})(0.050\\ \\mu\\mathrm{M}) = 0.50\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nNow we compute the velocities at the specified substrate concentrations:\n\nd) For $[S] = 5\\ \\mu\\mathrm{M}$:\n$$ v_{0, \\mathrm{VAR}} = \\frac{(0.50\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(5\\ \\mu\\mathrm{M})}{200\\ \\mu\\mathrm{M} + 5\\ \\mu\\mathrm{M}} = \\frac{2.5}{205}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = \\frac{1}{82}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} \\approx 0.012195\\dots\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nRounded to four significant figures, the velocity is $0.01220\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\ne) For $[S] = 20\\ \\mu\\mathrm{M}$:\n$$ v_{0, \\mathrm{VAR}} = \\frac{(0.50\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(20\\ \\mu\\mathrm{M})}{200\\ \\mu\\mathrm{M} + 20\\ \\mu\\mathrm{M}} = \\frac{10}{220}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = \\frac{1}{22}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} \\approx 0.0454545\\dots\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nRounded to four significant figures, the velocity is $0.04545\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\nf) For $[S] = 200\\ \\mu\\mathrm{M}$ (which is equal to $K_{M, \\mathrm{VAR}}$):\n$$ v_{0, \\mathrm{VAR}} = \\frac{(0.50\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(200\\ \\mu\\mathrm{M})}{200\\ \\mu\\mathrm{M} + 200\\ \\mu\\mathrm{M}} = \\frac{100}{400}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = 0.25\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nAs expected, the velocity is exactly half of $V_{\\mathrm{max, VAR}}$. Rounded to four significant figures, the velocity is $0.2500\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\nThe six computed velocities, rounded to four significant figures, are arranged in the specified order to form the final answer.", "answer": "$$\n\\boxed{\\begin{pmatrix} 1.000 & 2.500 & 4.545 & 0.01220 & 0.04545 & 0.2500 \\end{pmatrix}}\n$$", "id": "5032692"}, {"introduction": "Assessing the clinical significance of a variant requires integrating diverse data, from population frequency and computational predictions to the functional evidence explored in the previous exercises. This capstone practice introduces the powerful Bayesian framework used in modern variant interpretation, guiding you through the process of combining different lines of evidence, each with a specific weight, to calculate the posterior probability that a variant is pathogenic [@problem_id:5032669]. Completing this exercise will provide insight into how qualitative clinical guidelines are operationalized into a quantitative, evidence-based conclusion.", "problem": "A clinician evaluates a single-nucleotide coding variant in a gene where loss-of-function is an established disease mechanism. The evaluation follows the American College of Medical Genetics and Genomics (ACMG) categorical evidence framework. The categories applied to this variant are: one Pathogenic Very Strong ($\\text{PVS1}$) based on a predicted early truncating change consistent with loss-of-function, one Pathogenic Moderate ($\\text{PM}$) based on absence from large population datasets, two Pathogenic Supporting ($\\text{PP}$) based on multiple lines of in silico and conservation evidence suggesting a deleterious impact, and one Benign Strong ($\\text{BS}$) based on lack of segregation with disease in an adequately powered family.\n\nUse Bayes' theorem as the fundamental base: posterior odds equal prior odds multiplied by the product of the likelihood ratios contributed by independent evidence. Assume the following widely used likelihood ratio mappings for ACMG categories: $\\text{PVS1} \\mapsto 350$, $\\text{PS} \\mapsto 18.7$, $\\text{PM} \\mapsto 4.3$, $\\text{PP} \\mapsto 2.08$, $\\text{BS} \\mapsto 0.0535$, and $\\text{BP} \\mapsto 0.4807$. Assume independence of these evidence lines. Let the prior probability of pathogenicity for a missense or truncating variant in this gene-disease context be $0.1$, reflecting pre-test knowledge of variant pathogenicity in this gene and disease.\n\nStarting from Bayes' theorem and core definitions of odds and probability, derive an expression for the posterior odds of pathogenicity in terms of the prior odds and the evidence likelihood ratios, evaluate it for the specified evidence set, and convert the posterior odds to posterior probability. Express the final posterior probability of pathogenicity as a decimal and round your answer to four significant figures. Do not use a percentage sign.", "solution": "The problem requires the calculation of the posterior probability of pathogenicity for a genetic variant given a set of evidence criteria from the ACMG framework, a prior probability, and a set of likelihood ratio mappings for the evidence categories. The solution will proceed by first validating the problem statement and then performing the Bayesian calculation as requested.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n-   **Hypothesis:** The variant is pathogenic.\n-   **Established Disease Mechanism:** Loss-of-function.\n-   **Evidence Set:**\n    -   One Pathogenic Very Strong ($\\text{PVS1}$)\n    -   One Pathogenic Moderate ($\\text{PM}$)\n    -   Two Pathogenic Supporting ($\\text{PP}$)\n    -   One Benign Strong ($\\text{BS}$)\n-   **Likelihood Ratio (LR) Mappings:**\n    -   $LR(\\text{PVS1}) = 350$\n    -   $LR(\\text{PS}) = 18.7$\n    -   $LR(\\text{PM}) = 4.3$\n    -   $LR(\\text{PP}) = 2.08$\n    -   $LR(\\text{BS}) = 0.0535$\n    -   $LR(\\text{BP}) = 0.4807$\n-   **Assumption:** Independence of evidence lines.\n-   **Prior Probability of Pathogenicity:** $P(\\text{Pathogenic}) = 0.1$.\n-   **Fundamental Principle:** Bayes' theorem, expressed as: posterior odds = prior odds $\\times$ product of likelihood ratios.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is assessed to be valid.\n-   **Scientifically Grounded:** The problem uses the standard ACMG/AMP framework for variant interpretation and a Bayesian approach to combine evidence, which is a recognized and published methodology in medical genetics (e.g., Tavtigian et al., 2018, Genetics in Medicine). The LR values provided are consistent with those proposed in the field.\n-   **Well-Posed:** All necessary information is providedâ€”prior probability, a complete set of evidence, and corresponding likelihood ratios. The task is clearly defined: derive an expression, evaluate it, and convert the result to a probability.\n-   **Objective:** The problem is stated using precise, quantitative language and standard terminology, free from subjectivity. The conflicting evidence (both pathogenic and benign criteria) represents a realistic clinical scenario, not a contradiction.\n-   **Completeness:** The problem is self-contained. The provided LRs for $\\text{PS}$ and $\\text{BP}$ are not needed for this specific evidence set, but their inclusion does not create ambiguity.\n\n**Step 3: Verdict and Action**\nThe problem is valid and a solution can be derived.\n\n### Derivation and Calculation\n\nLet $H_P$ be the hypothesis that the variant is pathogenic, and $H_B$ be the alternative hypothesis that it is benign. Let $E$ represent the collection of all observed evidence.\n\nThe prior probability of pathogenicity is given as $P(H_P) = 0.1$. The prior probability of being benign is therefore $P(H_B) = 1 - P(H_P) = 1 - 0.1 = 0.9$.\n\nFirst, we convert the prior probability to prior odds. The odds of an event are defined as the ratio of the probability of the event occurring to the probability of it not occurring.\n$$\n\\text{Odds}(H_P) = \\frac{P(H_P)}{P(H_B)} = \\frac{P(H_P)}{1 - P(H_P)}\n$$\nSubstituting the given prior probability:\n$$\n\\text{Odds}(H_P) = \\frac{0.1}{1 - 0.1} = \\frac{0.1}{0.9} = \\frac{1}{9}\n$$\nThe problem states that Bayes' theorem can be expressed in terms of odds and likelihood ratios (LR). The posterior odds of pathogenicity given the evidence $E$ are the product of the prior odds and the likelihood ratio for the evidence:\n$$\n\\text{Odds}(H_P | E) = \\text{Odds}(H_P) \\times LR(E)\n$$\nThe likelihood ratio for a piece of evidence $E_i$ is defined as $LR(E_i) = \\frac{P(E_i | H_P)}{P(E_i | H_B)}$. Given the assumption that the lines of evidence are independent, the total likelihood ratio for the set of evidence $E = \\{E_1, E_2, \\ldots, E_n\\}$ is the product of the individual likelihood ratios:\n$$\nLR(E) = \\prod_{i=1}^{n} LR(E_i)\n$$\nCombining these, the expression for the posterior odds is:\n$$\n\\text{Odds}(H_P | E) = \\left( \\frac{P(H_P)}{1 - P(H_P)} \\right) \\times \\prod_{i=1}^{n} LR(E_i)\n$$\nThis is the derived expression. Now we evaluate it for the specified evidence set. The evidence consists of one $\\text{PVS1}$, one $\\text{PM}$, two $\\text{PP}$, and one $\\text{BS}$ criterion. The combined likelihood ratio, $LR_{\\text{combined}}$, is:\n$$\nLR_{\\text{combined}} = LR(\\text{PVS1}) \\times LR(\\text{PM}) \\times LR(\\text{PP}) \\times LR(\\text{PP}) \\times LR(\\text{BS})\n$$\n$$\nLR_{\\text{combined}} = LR(\\text{PVS1}) \\times LR(\\text{PM}) \\times (LR(\\text{PP}))^{2} \\times LR(\\text{BS})\n$$\nSubstituting the given numerical values for the likelihood ratios:\n$$\nLR_{\\text{combined}} = 350 \\times 4.3 \\times (2.08)^{2} \\times 0.0535\n$$\n$$\nLR_{\\text{combined}} = 350 \\times 4.3 \\times 4.3264 \\times 0.0535\n$$\n$$\nLR_{\\text{combined}} = 1505 \\times 4.3264 \\times 0.0535 \\approx 348.3518\n$$\nNext, we calculate the posterior odds of pathogenicity:\n$$\n\\text{Odds}(H_P | E) = \\text{Odds}(H_P) \\times LR_{\\text{combined}} = \\frac{1}{9} \\times 348.3518 \\approx 38.70576\n$$\nFinally, we convert the posterior odds back to a posterior probability. The relationship between probability $P$ and odds is $P = \\frac{\\text{Odds}}{1 + \\text{Odds}}$. Therefore, the posterior probability of pathogenicity, $P(H_P | E)$, is:\n$$\nP(H_P | E) = \\frac{\\text{Odds}(H_P | E)}{1 + \\text{Odds}(H_P | E)}\n$$\n$$\nP(H_P | E) = \\frac{38.70576}{1 + 38.70576} = \\frac{38.70576}{39.70576} \\approx 0.9748166\n$$\nRounding the final answer to four significant figures as requested gives $0.9748$.", "answer": "$$ \\boxed{0.9748} $$", "id": "5032669"}]}